000			02174 a2200625 4500
005			20250513235636.0
264		0	_c20010521
008			200105s 0 0 eng d
022			_a0025-6196
040			_aNLM _beng _cNLM
100	1		_aAppell, R A
245	0	0	_aProspective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. _h[electronic resource]
260			_bMayo Clinic proceedings _cApr 2001
300			_a358-63 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aBenzhydryl Compounds _xadministration & dosage
650	0	4	_aCresols _xadministration & dosage
650	0	4	_aDelayed-Action Preparations
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMandelic Acids _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aMuscarinic Antagonists _xadministration & dosage
650	0	4	_aNervous System Diseases _xchemically induced
650	0	4	_aPhenylpropanolamine
650	0	4	_aProbability
650	0	4	_aProspective Studies
650	0	4	_aReference Values
650	0	4	_aSeverity of Illness Index
650	0	4	_aStatistics, Nonparametric
650	0	4	_aTartrates _xadministration & dosage
650	0	4	_aTolterodine Tartrate
650	0	4	_aTreatment Outcome
650	0	4	_aUrinary Bladder, Neurogenic _xcomplications
650	0	4	_aUrinary Incontinence, Stress _xdiagnosis
650	0	4	_aUrination Disorders _xdiagnosis
650	0	4	_aXerostomia _xchemically induced
700	1		_aSand, P
700	1		_aDmochowski, R
700	1		_aAnderson, R
700	1		_aZinner, N
700	1		_aLama, D
700	1		_aRoach, M
700	1		_aMiklos, J
700	1		_aSaltzstein, D
700	1		_aBoone, T
700	1		_aStaskin, D R
700	1		_aAlbrecht, D
773	0		_tMayo Clinic proceedings _gvol. 76 _gno. 4 _gp. 358-63
999			_c11256423 _d11256423